CAS 111786-07-3

Prinoxodan

Description:

Prinoxodan, identified by its CAS number 111786-07-3, is a chemical compound that has garnered interest primarily in the field of pharmacology. It is recognized as a selective serotonin reuptake inhibitor (SSRI), which suggests its potential role in modulating serotonin levels in the brain, thereby influencing mood and emotional regulation. The compound is characterized by its ability to interact with serotonin transporters, leading to increased availability of serotonin in the synaptic cleft. This mechanism is commonly associated with antidepressant effects. Additionally, Prinoxodan may exhibit properties that could be beneficial in treating various mood disorders. Its chemical structure includes specific functional groups that contribute to its pharmacological activity, although detailed structural information is not provided here. As with many compounds in this category, the safety profile, efficacy, and potential side effects are critical areas of research, particularly in clinical settings. Overall, Prinoxodan represents a compound of interest in the ongoing exploration of treatments for mental health conditions.

Formula: C₁₃H₁₄N₄O₂

InChI: InChI=1/C13H14N4O2/c1-17-7-9-6-8(2-3-10(9)14-13(17)19)11-4-5-12(18)16-15-11/h2-3,6H,4-5,7H2,1H3,(H,14,19)(H,16,18)

SMILES: CN1Cc2cc(ccc2N=C1O)C1=NN=C(CC1)O

Synonyms:

• Prinoxodan [USAN:INN]
• 3,4-Dihydro-3-methyl-6-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2(1H)-quinazolinone
• Prinoxodano
• Prinoxodano [INN-Spanish]
• Prinoxodanum
• Prinoxodanum [INN-Latin]
• Rgw 2938
• Unii-W4Vmh2E80M
• 2(1H)-Quinazolinone, 3,4-dihydro-3-methyl-6-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-
• 3-methyl-6-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-3,4-dihydroquinazolin-2(1H)-one

Reversan

CAS: 111786-07-3

Reversan

Purity: ≥98%

Molecular weight: 441.53g/mol

Ref: 54-BUP20545

Prinoxodan

CAS: 111786-07-3

Prinoxodan is a pharmaceutical dosage form of fatty acid. It is used in the diagnosis and treatment of muscle cells, as well as other diseases that are associated with muscle degeneration. Prinoxodan is reconstituted for injection and administered intravenously. The drug has an enhancement effect on the uptake by muscle cells, which enhances the intracellular concentration of fatty acids and increases their availability to the mitochondria, which leads to increased synthesis of mitochondria proteins. The conjugates also have a serotonin-releasing effect, which may lead to improved mood.

Formula: C₁₃H₁₄N₄O₂

Purity: Min. 95%

Molecular weight: 258.28 g/mol

Ref: 3D-LEA78607

Prinoxodan

CAS: 111786-07-3

Prinoxodan is an inhibitor of phosphodiesterase.

Formula: C₁₃H₁₄N₄O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 258.28

Ref: TM-T12720